{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:18:52Z","timestamp":1791242332728,"version":"4.1.0"},"reference-count":264,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Wilson\u2019s disease (WD) is a rare, autosomal recessive disorder of copper metabolism caused by pathogenic mutations in the ATP7B gene. Cellular copper overload is associated with impaired iron metabolism. Oxidative stress, cuproptosis, and ferroptosis are involved in cell death in WD. The clinical picture of WD is variable. Hepatic\/neuropsychiatric\/other symptoms may manifest in childhood\/adulthood and even old age. It has been shown that phenotypic variability may be determined by the type of ATP7B genetic variants as well as the influence of various genetic\/epigenetic, environmental, and lifestyle modifiers. In 1976, immunological abnormalities were first described in patients with WD. These included an increase in IgG and IgM levels and a decrease in the percentage of T lymphocytes, as well as a weakening of their bactericidal effect. Over the following years, it was shown that there is a bidirectional relationship between copper and inflammation. Changes in serum cytokine concentrations and the relationship between cytokine gene variants and the clinical course of the disease have been described in WD patients, as well as in animal models of this disease. Data have also been published on the occurrence of antinuclear antibodies (ANAs), antineutrophil cytoplasmic antibodies (ANCAs), anti-muscle-specific tyrosine kinase antibodies, and anti-acetylcholine receptor antibodies, as well as various autoimmune diseases, including systemic lupus erythematosus (SLE), myasthenic syndrome, ulcerative colitis, multiple sclerosis (MS), polyarthritis, and psoriasis after treatment with d-penicillamine (DPA). The occurrence of autoantibodies was also described, the presence of which was not related to the type of treatment or the form of the disease (hepatic vs. neuropsychiatric). The mechanisms responsible for the occurrence of autoantibodies in patients with WD are not known. It has also not been clarified whether they have clinical significance. In some patients, WD was differentiated or coexisted with an autoimmune disease, including autoimmune hepatitis or multiple sclerosis. Various molecular mechanisms may be responsible for immunological abnormalities and\/or the inflammatory processes in WD. Their better understanding may be important for explaining the reasons for the diversity of symptoms and the varied course and response to therapy, as well as for the development of new treatment regimens for WD.<\/jats:p>","DOI":"10.3390\/ijms25169034","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T09:13:48Z","timestamp":1724145228000},"page":"9034","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Wilson\u2019s Disease\u2014Crossroads of Genetics, Inflammation and Immunity\/Autoimmunity: Clinical and Molecular Issues"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4325-8971","authenticated-orcid":false,"given":"Gra\u017cyna","family":"Gromadzka","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszynski University, W\u00f3ycickiego Street 1\/3, 01-938 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Czerwi\u0144ska","sequence":"additional","affiliation":[{"name":"Students Scientific Association \u201cImmunis\u201d, Cardinal Stefan Wyszynski University, Dewajtis Street 5, 01-815 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Krzemi\u0144ska","sequence":"additional","affiliation":[{"name":"Students Scientific Association \u201cImmunis\u201d, Cardinal Stefan Wyszynski University, Dewajtis Street 5, 01-815 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5851-2856","authenticated-orcid":false,"given":"Adam","family":"Przyby\u0142kowski","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Internal Medicine, Medical University of Warsaw, Banacha 1a, 02-097 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2670-9651","authenticated-orcid":false,"given":"Tomasz","family":"Litwin","sequence":"additional","affiliation":[{"name":"Second Department of Neurology, Institute of Psychiatry and Neurology, Sobieskiego Street 9, 02-957 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/mds.20694","article-title":"History of Wilson\u2019s disease: 1912 to 2000","volume":"21","author":"Walshe","year":"2006","journal-title":"Mov. Disord."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.3390\/ijms16036419","article-title":"Wilson\u2019s disease: A comprehensive review of the molecular mechanisms","volume":"16","author":"Wu","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1056\/NEJMra1903585","article-title":"Current and Emerging Issues in Wilson\u2019s Disease","volume":"389","author":"Roberts","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ovchinnikova, E.V., Garbuz, M.M., Ovchinnikova, A.A., and Kumeiko, V.V. (2024). Epidemiology of Wilson\u2019s Disease and Pathogenic Variants of the ATP7B Gene Leading to Diversified Protein Disfunctions. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25042402"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"8981","DOI":"10.3748\/wjg.v21.i29.8981","article-title":"Wilson disease with hepatic presentation in an eight-month-old boy","volume":"21","author":"Abuduxikuer","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1053\/j.gastro.2007.02.057","article-title":"Late-onset Wilson\u2019s disease","volume":"132","author":"Ferenci","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/mds.21985","article-title":"Late onset Wilson\u2019s disease: Therapeutic implications","volume":"23","author":"Rodo","year":"2008","journal-title":"Mov. Disord."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0022-510X(76)90188-X","article-title":"Immunological observations on patients with Wilson\u2019s disease","volume":"29","author":"Milewski","year":"1976","journal-title":"J. Neurol. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/B978-0-444-63625-6.00009-4","article-title":"Hepatic features of Wilson disease","volume":"142","author":"Boga","year":"2017","journal-title":"Handb. Clin. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00404-009-1080-6","article-title":"Clinical features of hemolysis, elevated liver enzymes, and low platelet count syndrome in undiagnosed Wilson disease: Report of two cases","volume":"281","author":"Gromadzka","year":"2010","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.biocel.2018.07.001","article-title":"Mitochondrial copper homeostasis and its derailment in Wilson disease","volume":"102","author":"Zischka","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.advms.2022.04.003","article-title":"Liver injury in Wilson\u2019s disease: An immunohistochemical study","volume":"67","author":"Szeligowska","year":"2022","journal-title":"Adv. Med. Sci."},{"key":"ref_13","first-page":"4336","article-title":"Liver changes in Wilson\u2019s disease: The full spectrum. A report of 127 biopsies from 43 patients","volume":"25","author":"Fanni","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/ajcp\/73.1.12","article-title":"Histology of the liver in Wilson\u2019s disease: A study of 34 cases","volume":"73","author":"Stromeyer","year":"1980","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_15","first-page":"s00441786855","article-title":"Wilson disease: The diagnostic challenge and treatment outcomes in a series of 262 cases","volume":"82","author":"Deguti","year":"2024","journal-title":"Arq. Neuropsiquiatr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.21037\/atm.2019.02.43","article-title":"Neurologic impairment in Wilson disease","volume":"7","author":"Dusek","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Jopowicz, A., and Tarnacka, B. (2023). Neurological Wilson\u2019s Disease Signs-Hepatic Encephalopathy or Copper Toxicosis?. Diagnostics, 13.","DOI":"10.3390\/diagnostics13050893"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1007\/s10072-022-06001-2","article-title":"Brain magnetic resonance imaging and severity of neurological disease in Wilson\u2019s disease-the neuroradiological correlations","volume":"43","author":"Bembenek","year":"2022","journal-title":"Neurol. Sci."},{"key":"ref_19","first-page":"73","article-title":"Neuropathological analysis of pathological forms of astroglia in Wilson\u2019s disease","volume":"39","author":"Bertrand","year":"2001","journal-title":"Folia. Neuropathol."},{"key":"ref_20","first-page":"125","article-title":"Morphological analysis of active microglia--rod and ramified microglia in human brains affected by some neurological diseases (SSPE, Alzheimer\u2019s disease and Wilson\u2019s disease)","volume":"40","author":"Gwiazda","year":"2002","journal-title":"Folia. Neuropathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1080\/00207454.2020.1849190","article-title":"Effect of homeostatic iron regulator protein gene mutation on Wilson\u2019s disease clinical manifestation: Original data and literature review","volume":"132","author":"Gromadzka","year":"2022","journal-title":"Int. J. Neurosci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10534-021-00289-x","article-title":"Iron metabolism is disturbed and anti-copper treatment improves but does not normalize iron metabolism in Wilson\u2019s disease","volume":"34","author":"Gromadzka","year":"2021","journal-title":"Biometals"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"126637","DOI":"10.1016\/j.jtemb.2020.126637","article-title":"Difference in iron metabolism may partly explain sex-related variability in the manifestation of Wilson\u2019s disease","volume":"62","author":"Gromadzka","year":"2020","journal-title":"J. Trace Elem. Med. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jns.2013.03.021","article-title":"Brain metal accumulation in Wilson\u2019s disease","volume":"329","author":"Litwin","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"ref_26","unstructured":"Koppenol, W., and Bounds, P. (2011). Redox-active metals: Iron and copper. Principles of Free Radical Biomedicine, Nova Science."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1038\/cddis.2011.134","article-title":"DNA damage induces reactive oxygen species generation through the H2AX-Nox1\/Rac1 pathway","volume":"12","author":"Kang","year":"2012","journal-title":"Cell Death Dis."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Kowalczyk, P., Sulejczak, D., Kleczkowska, P., Bukowska-O\u015bko, I., Kucia, M., Popiel, M., Wietrak, E., Kramkowski, K., Wrzosek, K., and Kaczy\u0144ska, K. (2021). Mitochondrial Oxidative Stress-A Causative Factor and Therapeutic Target in Many Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222413384"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/nyas.12347","article-title":"Pathological mitochondrial copper overload in livers of Wilson\u2019s disease patients and related animal models","volume":"1315","author":"Zischka","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1172\/JCI45401","article-title":"Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease","volume":"121","author":"Zischka","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5080843","DOI":"10.1155\/2019\/5080843","article-title":"Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis","volume":"2019","author":"Su","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1007\/s12011-022-03277-5","article-title":"Antioxidant Capacity Is Decreased in Wilson\u2019s Disease and Correlates to Liver Function","volume":"201","author":"Gromadzka","year":"2023","journal-title":"Biol. Trace Elem. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/liv.12493","article-title":"Gene variants encoding proteins involved in antioxidant defense system and the clinical expression of Wilson disease","volume":"35","author":"Gromadzka","year":"2015","journal-title":"Liver Int."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10534-014-9706-y","article-title":"Treatment with D-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease","volume":"27","author":"Gromadzka","year":"2014","journal-title":"Biometals"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Wang, D., Tian, Z., Zhang, P., Zhen, L., Meng, Q., Sun, B., Xu, X., Jia, T., and Li, S. (2023). The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease. Biomed. Pharmacother., 163.","DOI":"10.1016\/j.biopha.2023.114830"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.molcel.2022.05.001","article-title":"Cuproptosis: Cellular and molecular mechanisms underlying copper-induced cell death","volume":"82","author":"Cobine","year":"2022","journal-title":"Mol. Cell."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cbpa.2017.11.003","article-title":"Protein lipoylation: An evolutionarily conserved metabolic regulator of health and disease","volume":"42","author":"Rowland","year":"2018","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Kang, W., Suzuki, M., Saito, T., and Miyado, K. (2021). Emerging Role of TCA Cycle-Related Enzymes in Human Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222313057"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","article-title":"Copper homeostasis and cuproptosis in health and disease","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11596-024-2832-z","article-title":"Copper Metabolism and Cuproptosis: Molecular Mechanisms and Therapeutic Perspectives in Neurodegenerative Diseases","volume":"44","author":"Ban","year":"2024","journal-title":"Curr. Med. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1007\/s11427-022-2106-6","article-title":"Cuproptosis: Copper-induced regulated cell death","volume":"65","author":"Duan","year":"2022","journal-title":"Sci. China Life Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"218","DOI":"10.7150\/ijbs.84733","article-title":"The Cross-Communication of Cuproptosis and Regulated Cell Death in Human Pathophysiology","volume":"20","author":"Tsui","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12943-023-01732-y","article-title":"Cuproptosis: Mechanisms and links with cancers","volume":"22","author":"Xie","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2741\/2067","article-title":"Glutamine in the central nervous system: Function and dysfunction","volume":"12","author":"Albrecht","year":"2007","journal-title":"Front. Biosci."},{"key":"ref_45","first-page":"377","article-title":"Impairment of glutamine\/glutamate-\u03b3-aminobutyric acid cycle in manganese toxicity in the central nervous system","volume":"52","year":"2014","journal-title":"Folia Neuropathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0163-7258(02)00328-5","article-title":"Molecular aspects of glutamate dysregulation: Implications for schizophrenia and its treatment","volume":"97","author":"Konradi","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.bbamcr.2012.01.005","article-title":"The taste of heavy metals: Gene regulation by MTF-1","volume":"1823","author":"Lindert","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Pan, Z., Huang, L., Gan, Y., Xia, Y., and Yu, W. (2024). The Molecular Mechanisms of Cuproptosis and Small-Molecule Drug Design in Diabetes Mellitus. Molecules, 29.","DOI":"10.3390\/molecules29122852"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: Mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s43556-023-00142-2","article-title":"The mechanism of ferroptosis and its related diseases","volume":"4","author":"Feng","year":"2023","journal-title":"Mol. Biomed."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41392-020-00216-5","article-title":"The interaction between ferroptosis and lipid metabolism in cancer","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"103211","DOI":"10.1016\/j.redox.2024.103211","article-title":"Ferroptosis in health and disease","volume":"75","author":"Berndt","year":"2024","journal-title":"Redox Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"103259","DOI":"10.1016\/j.redox.2024.103259","article-title":"Protein modification and degradation in ferroptosis","volume":"75","author":"Wang","year":"2024","journal-title":"Redox Biol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Wu, H., Wang, F., Ta, N., Zhang, T., and Gao, W. (2021). The Multifaceted Regulation of Mitochondria in Ferroptosis. Life, 11.","DOI":"10.3390\/life11030222"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41419-021-04128-2","article-title":"CISD3 inhibition drives cystine-deprivation induced ferroptosis","volume":"12","author":"Li","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"109762","DOI":"10.1016\/j.intimp.2023.109762","article-title":"FGF4 improves hepatocytes ferroptosis in autoimmune hepatitis mice via activation of CISD3","volume":"116","author":"Jiang","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","article-title":"Role of Mitochondria in Ferroptosis","volume":"73","author":"Gao","year":"2019","journal-title":"Mol. Cell."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41422-022-00653-7","article-title":"Cuproptosis: A copper-triggered modality of mitochondrial cell death","volume":"32","author":"Tang","year":"2022","journal-title":"Cell. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1335122","DOI":"10.3389\/fnagi.2024.1335122","article-title":"Emerging insights into cuproptosis and copper metabolism: Implications for age-related diseases and potential therapeutic strategies. Front","volume":"16","author":"Fan","year":"2024","journal-title":"Aging Neurosci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12964-024-01625-7","article-title":"Cuproptosis: Unveiling a new frontier in cancer biology and therapeutics","volume":"22","author":"Feng","year":"2024","journal-title":"Cell. Commun. Signal"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e169756","DOI":"10.1172\/jci.insight.169756","article-title":"Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity","volume":"8","author":"Tadokoro","year":"2023","journal-title":"JCI Insight"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: Molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Battaglia, A.M., Chirillo, R., Aversa, I., Sacco, A., Costanzo, F., and Biamonte, F. (2020). Ferroptosis and Cancer: Mitochondria Meet the \u201cIron Maiden\u201d Cell Death. Cells, 9.","DOI":"10.3390\/cells9061505"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Liu, N., and Chen, M. (2024). Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application. Biomed. Pharmacother., 171.","DOI":"10.1016\/j.biopha.2023.116115"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41586-020-03048-z","article-title":"Small-molecule inhibitors of human mitochondrial DNA transcription","volume":"588","author":"Bonekamp","year":"2020","journal-title":"Nature"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fnins.2018.00214","article-title":"Oxytosis\/ferroptosis-(Re-) emerging roles for oxidative stress-dependent non-apoptotic cell death in diseases of the central nervous system","volume":"12","author":"Lewerenz","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.redox.2017.03.007","article-title":"BID links ferroptosis to mitochondrial cell death pathways","volume":"12","author":"Neitemeier","year":"2017","journal-title":"Redox Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1029092","DOI":"10.3389\/fimmu.2022.1029092","article-title":"Cross-talk between cuproptosis and ferroptosis regulators defines the tumor microenvironment for the prediction of prognosis and therapies in lung adenocarcinoma","volume":"13","author":"Shen","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.chembiol.2020.02.005","article-title":"Autophagy-Dependent Ferroptosis: Machinery and Regulation","volume":"27","author":"Liu","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"eaaw2238","DOI":"10.1126\/sciadv.aaw2238","article-title":"Clockophagy is a novel selective autophagy process favoring ferroptosis","volume":"5","author":"Yang","year":"2019","journal-title":"Sci. Adv."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/cr.2016.95","article-title":"Ferroptosis is an autophagic cell death process","volume":"26","author":"Gao","year":"2016","journal-title":"Cell. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"7038","DOI":"10.1111\/febs.16059","article-title":"Signaling pathways and defense mechanisms of ferroptosis","volume":"289","author":"Liu","year":"2022","journal-title":"FEBS J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/s41419-019-2064-5","article-title":"ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation","volume":"10","author":"Park","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2249.2006.03261.x","article-title":"Chronic inflammation: Importance of NOD2 and NALP3 in interleukin-1beta generation","volume":"147","author":"Nielsen","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","article-title":"Nonresolving inflammation","volume":"140","author":"Nathan","year":"2010","journal-title":"Cell."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"16867","DOI":"10.18632\/aging.103585","article-title":"Oxidative stress, apoptosis and inflammatory responses involved in copper-induced pulmonary toxicity in mice","volume":"12","author":"Jian","year":"2020","journal-title":"Aging"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2147\/JIR.S275595","article-title":"Reactive Oxygen Species: Drivers of Physiological and Pathological Processes","volume":"13","author":"Checa","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"610813","DOI":"10.1155\/2015\/610813","article-title":"Interrelation of oxidative stress and inflammation in neurodegenerative disease: Role of TNF","volume":"2015","author":"Fischer","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.bbadis.2013.09.014","article-title":"Tuning NF-\u03baB activity. A touch of COMMD proteins","volume":"1832","author":"Bartuzi","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Gromadzka, G., Tarnacka, B., Flaga, A., and Adamczyk, A. (2020). Copper dyshomeostasis in Neurodegenerative Diseases-Therapeutic Implications. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21239259"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.neuro.2009.03.005","article-title":"Effect of copper on extracellular levels of key pro-inflammatory molecules in hypothalamic GN11 and primary neurons","volume":"30","author":"Spisni","year":"2009","journal-title":"NeuroToxicology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0142-9612(98)00075-1","article-title":"Influence of metals on IL-6 release in vitro","volume":"19","author":"Schmalz","year":"1998","journal-title":"Biomaterials"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.26047","article-title":"Wilson\u2019s disease. Changes in methionine metabolism and inflammation affect global DNA methylation in early liver disease","volume":"57","author":"Medici","year":"2013","journal-title":"Hepatology"},{"key":"ref_86","first-page":"500","article-title":"Morphologic and chemical studies on a murine mutation (Toxic Milk Mice) resulting in hepatic copper toxicosis","volume":"59","author":"Biempica","year":"1988","journal-title":"Lab. Investig."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/hep.1840150116","article-title":"D-penicillamine prevents the development of hepatitis in Long-Evans Cinnamon rats with abnormal copper metabolism","volume":"15","author":"Togashi","year":"1992","journal-title":"Hepatology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/01.mcg.0000225670.91722.59","article-title":"Diagnosis and management of Wilson\u2019s disease: Results of a single center experience","volume":"40","author":"Medici","year":"2006","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.21037\/atm-21-2264","article-title":"Wilson disease and the differential diagnosis of its hepatic manifestations: A narrative review of clinical, laboratory, and liver histological features","volume":"9","author":"Schroeder","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10072-018-3680-z","article-title":"Inflammatory cytokines expression in Wilson\u2019s disease","volume":"40","author":"Wu","year":"2019","journal-title":"Neurol. Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1089\/ars.2006.8.1897","article-title":"Copper activates the NF-kappaB pathway in vivo","volume":"8","author":"Persichini","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Sandoval, C., R\u00edos, G., Sep\u00falveda, N., Salvo, J., Souza-Mello, V., and Far\u00edas, J. (2022). Effectiveness of Copper Nanoparticles in Wound Healing Process Using In Vivo and In Vitro Studies: A Sys-tematic Review. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14091838"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"111060","DOI":"10.1016\/j.cbi.2024.111060","article-title":"Copper exposure induces inflammation and PANoptosis through the TLR4\/NF-\u03baB signaling pathway, leading to testicular damage and impaired spermatogenesis in Wilson disease","volume":"396","author":"Zhao","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1186\/s12951-024-02707-x","article-title":"MMP-3 mediates copper oxide nanoparticle-induced pulmonary inflammation and fibrosis","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"116430","DOI":"10.1016\/j.ecoenv.2024.116430","article-title":"Cu exposure induces liver inflammation via regulating gut microbiota\/LPS\/liver TLR4 signaling axis","volume":"15","author":"Gu","year":"2024","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Ho, W.I., Hu, Y., Cheng, C.W., Wei, R., Yang, J., Li, N., Au, K.W., Tse, Y.L., Wang, Q., and Ng, K.M. (2022). Liposome-encapsulated curcumin attenuates HMGB1-mediated hepatic inflammation and fibrosis in a murine model of Wilson\u2019s disease. Biomed. Pharmacother., 152.","DOI":"10.1016\/j.biopha.2022.113197"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"20703","DOI":"10.1074\/jbc.270.35.20703","article-title":"Copper binding to mouse liver S-adenosylhomocysteine hydrolase and the effects of copper on its levels","volume":"270","author":"Bethin","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1007\/s00018-008-8201-4","article-title":"Early effects of copper accumulation on methionine metabolism","volume":"65","author":"Delgado","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.23382","article-title":"Epigenetic regulation of hepatic endoplasmic reticulum stress in the ethanol-fed cystathionine beta synthase-deficient mouse","volume":"51","author":"Esfandiari","year":"2010","journal-title":"Hepatology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"829","DOI":"10.4161\/epi.6.7.16353","article-title":"A genomic point-of-view on environmental factors influencing the human brain methylome","volume":"6","author":"LaSalle","year":"2011","journal-title":"Epigenetics"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1053\/j.gastro.2011.12.058","article-title":"Folic Acid Increases Global DNA Methylation and Reduces Inflammation to Prevent Helicobacter-Associated Gastric Cancer in Mice","volume":"142","author":"Gonda","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"20698","DOI":"10.1074\/jbc.270.35.20698","article-title":"Identification of a major hepatic copper binding protein as S-adenosylhomocysteine hydrolase","volume":"270","author":"Bethin","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s12276-022-00736-w","article-title":"The mechanism of HMGB1 secretion and release","volume":"54","author":"Chen","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"996307","DOI":"10.3389\/fcell.2022.996307","article-title":"HMGB1 is a mediator of cuproptosis-related sterile inflammation","volume":"10","author":"Liu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_105","first-page":"730","article-title":"HMGB1 regulates erastin-induced ferroptosis via RAS-JNK\/p38 signaling in HL-60\/NRASQ61L cells","volume":"9","author":"Ye","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"An, Y., Li, S., Huang, X., Chen, X., Shan, H., and Zhang, M. (2022). The Role of Copper Homeostasis in Brain Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232213850"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s007020050026","article-title":"CSF copper concentrations, blood-brain barrier function, and ceruloplasmin synthesis during the treatment of Wilson\u2019s disease","volume":"107","author":"Stuerenburg","year":"2000","journal-title":"J. Neural. Transm."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/brain\/awab274","article-title":"Neuroimaging correlates of brain injury in Wilson\u2019s disease: A multimodal, whole-brain MRI study","volume":"145","author":"Shribman","year":"2022","journal-title":"Brain"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/jn\/nxz172","article-title":"Animal Models of Normal and Disturbed Iron and Copper Metabolism","volume":"149","author":"Wang","year":"2019","journal-title":"J. Nutr."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s12031-020-01654-0","article-title":"Movement disorder in Wilson disease. Correlation with MRI and biomarkers of cell injury","volume":"71","author":"Kalita","year":"2020","journal-title":"J. Mol. Neurosci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/00207454.2010.523131","article-title":"Influence of IL-1RN intron 2 variable number of tandem repeats (VNTR) polymorphism on the age at onset of neuropsychiatric symptoms in Wilson\u2019s disease","volume":"121","author":"Gromadzka","year":"2011","journal-title":"Int. J. Neurosci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.neurobiolaging.2004.04.001","article-title":"Genotypes and haplotypes in the IL-1 gene cluster: Analysis of two genetically and diagnostically distinct groups of Alzheimer patients","volume":"26","author":"Seripa","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12264-016-0055-4","article-title":"Inflammatory Cytokines and Alzheimer\u2019s Disease: A Review from the Perspective of Genetic Polymorphisms","volume":"32","author":"Su","year":"2016","journal-title":"Neurosci. Bull."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jns.2008.02.021","article-title":"Genetic analysis of tumour necrosis factor-alpha (TNF-alpha) G-308A and Saitohin Q7R polymorphisms with Alzheimer\u2019s disease","volume":"270","author":"Wang","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Watanabe, H., and Son, M. (2021). The Immune Tolerance Role of the HMGB1-RAGE Axis. Cells, 10.","DOI":"10.3390\/cells10030564"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Huber, R., Meier, B., Otsuka, A., Fenini, G., Satoh, T., Gehrke, S., Widmer, D., Levesque, M.P., Mangana, J., and Kerl, K. (2016). Tumour hypoxia promotes melanoma growth and metastasis via High Mobility Group Box-1 and M2-like macrophages. Sci. Rep., 6.","DOI":"10.1038\/srep29914"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1182\/blood-2016-05-719757","article-title":"C1q and HMGB1 reciprocally regulate human macrophage polarization","volume":"128","author":"Son","year":"2016","journal-title":"Blood"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.plefa.2012.11.009","article-title":"Arachidonic acid and lipoxin A4 as possible endogenous anti-diabetic molecules","volume":"88","author":"Das","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: Signals in resolution","volume":"2","author":"Levy","year":"2001","journal-title":"Nat. Immunol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"23254","DOI":"10.1073\/pnas.1907490116","article-title":"HMGB1-C1q complexes regulate macrophage function by switching between leukotriene and specialized proresolving mediator biosynthesis","volume":"116","author":"Liu","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e85375","DOI":"10.1172\/jci.insight.85375","article-title":"Identification of CD163 as an anti-inflammatory receptor for HMGB1-haptoglobin complexes","volume":"1","author":"Yang","year":"2016","journal-title":"JCI Insight"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"7783","DOI":"10.1073\/pnas.1722056115","article-title":"CD52 glycan binds the proinflammatory B box of HMGB1 to engage the Siglec-10 receptor and suppress human T cell function","volume":"115","author":"Bediaga","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Wang, J., Li, J., Liu, J., Chan, K.Y., Lee, H.S., Lin, K.N., Wang, C.C., and Lau, T.S. (2024). Interplay of Ferroptosis and Cuproptosis in Cancer: Dissecting Metal-Driven Mechanisms for Therapeutic Potentials. Cancers, 16.","DOI":"10.3390\/cancers16030512"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41586-022-05443-0","article-title":"Ferroptosis of tumour neutrophils causes immune suppression in cancer","volume":"612","author":"Kim","year":"2022","journal-title":"Nature"},{"key":"ref_125","first-page":"6","article-title":"Neutrophil ferroptosis causes immunosuppression","volume":"23","author":"Flemming","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/j.scib.2021.02.026","article-title":"Ferroptosis: An emerging player in immune cells","volume":"66","author":"Xu","year":"2021","journal-title":"Sci Bull"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"797339","DOI":"10.3389\/fcell.2021.797339","article-title":"LncRNAs Target Ferroptosis-Related Genes and Impair Activation of CD4+ T Cell in Gastric Cancer","volume":"9","author":"Yao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1158\/0008-5472.CAN-20-0471","article-title":"Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion","volume":"80","author":"Voli","year":"2020","journal-title":"Cancer Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/j.1460-2075.1992.tb05481.x","article-title":"Induced expressionof PD-1, a novel member of the immunoglobulin gene superfamily upon programmed cell death","volume":"11","author":"Ishida","year":"1992","journal-title":"EMBO J."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.autrev.2013.05.003","article-title":"Recent insights into the role of the PD-1\/PD-L1 pathway in immunological tolerance and autoimmunity","volume":"12","author":"Gianchecchi","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/intimm\/8.5.765","article-title":"Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes","volume":"8","author":"Agata","year":"1996","journal-title":"Int. Immunol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1084\/jem.20061800","article-title":"Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade","volume":"203","author":"Freeman","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"6738","DOI":"10.4049\/jimmunol.181.10.6738","article-title":"The common g-chain cytokines IL-2, IL-7,IL-15, and IL-21 induce the expression of programmed death-1 and its ligands","volume":"181","author":"Kinter","year":"2008","journal-title":"J. Immunol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-065X.2009.00767.x","article-title":"PD-1 signaling in primary T cells","volume":"229","author":"Riley","year":"2009","journal-title":"Immunol Rev."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrclinonc.2015.105","article-title":"Inflammation and cancer: Advances and new agents","volume":"12","author":"Crusz","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.virol.2014.12.033","article-title":"T cell exhaustion during persistent viral infections","volume":"479","author":"Kahan","year":"2015","journal-title":"Virology"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1600-065X.2008.00638.x","article-title":"Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections","volume":"223","author":"Ha","year":"2008","journal-title":"Immunol. Rev."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cell.2005.12.039","article-title":"CRIg: A macrophage complement receptor required for phagocytosis of circulating pathogens","volume":"124","author":"Helmy","year":"2006","journal-title":"Cell"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.1840040109","article-title":"Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis","volume":"4","author":"Rimola","year":"1984","journal-title":"Hepatology"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/hep.1840060217","article-title":"Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis","volume":"6","author":"Rajkovic","year":"1986","journal-title":"Hepatology"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1086\/315742","article-title":"In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease","volume":"182","author":"Fiuza","year":"2000","journal-title":"J. Infect. Dis."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jhep.2010.11.034","article-title":"Evidence of neutrophil functional defect despite inflammation in stable cirrhosis","volume":"55","author":"Tritto","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s10156-004-0321-7","article-title":"Opsonophagocytic dysfunction in patients with liver cirrhosis and low responses to tumor necrosis factor-a and lipopolysaccharide in patients\u2019 blood","volume":"10","author":"Ono","year":"2004","journal-title":"J. Infect. Chemother."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jhep.2003.12.010","article-title":"Tumour necrosis factor-alpha expression by activated monocytes and altered T-cell homeostasis in ascitic alcoholic cirrhosis: Amelioration with norfloxacin","volume":"40","author":"Albillos","year":"2004","journal-title":"J. Hepatol."},{"key":"ref_148","first-page":"907","article-title":"Populations of circulating T lymphocytes in patients with alcoholic cirrhosis","volume":"8","author":"Perrin","year":"1984","journal-title":"Gastroenterol. Clin. Biol."},{"key":"ref_149","first-page":"1803","article-title":"Peripheral lymphocyte subsets vary with stage of hepatitis C virus-associated liver disease","volume":"52","author":"Morita","year":"2005","journal-title":"Hepatogastroenterology"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/509580","article-title":"The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients","volume":"44","author":"McGovern","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jhep.2013.05.042","article-title":"Defective thymopoiesis and poor peripheral homeostatic replenishment of T-helper cells cause T-cell lymphopenia in cirrhosis","volume":"59","author":"Lario","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_152","first-page":"377","article-title":"Decreased proliferative activity associated with activation markers in patients with alcoholic liver cirrhosis","volume":"72","author":"Deviere","year":"1988","journal-title":"Clin. Exp. Immunol."},{"key":"ref_153","first-page":"767","article-title":"T lymphocytes from alcoholic cirrhotic patients show normal interleukin-2 production but a defective proliferative response to polyclonal mitogens","volume":"89","author":"Manzano","year":"1994","journal-title":"Am. J. Gastroenterol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2893.2011.01562.x","article-title":"Antigen-specific T lymphocyte proliferation decreases over time in advanced chronic hepatitis C","volume":"19","author":"Morishima","year":"2012","journal-title":"J. Viral. Hepat."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/hep.510250508","article-title":"Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption","volume":"25","author":"Laso","year":"1997","journal-title":"Hepatology"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Cz\u0142onkowska, A., Niewada, M., Litwin, T., Krai\u0144ski, \u0141., Skowro\u0144ska, M., Piechal, A., Antos, A., Misztal, M., Khanna, I., and Kurkowska-Jastrz\u0119bska, I. (2022). Seven decades of clinical experience with Wilson\u2019s disease: Report from the national reference centre in Poland. Eur. J. Neurol.","DOI":"10.1111\/ene.15646"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"101768","DOI":"10.1016\/j.bpg.2021.101768","article-title":"Wilson\u2019s disease- management and long term outcomes","volume":"56","author":"Socha","year":"2022","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41572-018-0018-3","article-title":"Wilson disease","volume":"4","author":"Litwin","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/B978-0-444-63625-6.00015-X","article-title":"Wilson disease\u2014Currently used anticopper therapy","volume":"142","author":"Czlonkowska","year":"2017","journal-title":"Handb. Clin. Neurol."},{"key":"ref_160","unstructured":"Kerkar, N., and Roberts, E.A. (2019). Oral Chelator Treatment of Wilson Disease: D-Penicillamine. Clinical and Translational Perspectives on WILSON DISEASE, Academic Press. Chapter 34."},{"key":"ref_161","first-page":"15","article-title":"D-p\u00e9nicillamine: M\u00e9canisme d\u2019action cellulaire et maladies auto-immunes induites [D-penicillamine: Mechanism of cellular action and induced autoimmune diseases]","volume":"53","author":"Meyer","year":"1986","journal-title":"Rev. Rhum. Mal. Osteoartic."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1021\/tx900128p","article-title":"D-penicillamine-induced autoimmunity: Relationship to macrophage activation","volume":"22","author":"Li","year":"2009","journal-title":"Chem. Res. Toxicol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/art.1780331018","article-title":"D-penicillamine-induced lupus erythematosus","volume":"33","author":"Enzenauer","year":"1990","journal-title":"Arthritis Rheum."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.3346\/jkms.2019.34.e173","article-title":"A pediatric case of a D-Penicillamine induced ANCA-associated vasculitis manifesting a pulmonary-renal syndrome","volume":"34","author":"Kang","year":"2019","journal-title":"J. Korean Med. Sci."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneuroim.2012.05.011","article-title":"Anti- MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine","volume":"250","author":"Poulas","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(71)91022-1","article-title":"Lupus-like syndrome induced by D-penicillamine in Wilson\u2019s disease","volume":"1","author":"Harpey","year":"1971","journal-title":"Lancet"},{"key":"ref_167","first-page":"155","article-title":"Penicillamine and the SLE syndrome","volume":"7","author":"Walshe","year":"1981","journal-title":"J. Rheumatol. Suppl."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/096120339500400104","article-title":"Liver transplantation in patients with systemic lupus erythematosus","volume":"4","author":"Barthel","year":"1995","journal-title":"Lupus"},{"key":"ref_169","first-page":"55","article-title":"Wilson\u2019s disease treated with penicillamine and lupus erythematosus: Related or distinct entities?","volume":"64","author":"Boati","year":"2012","journal-title":"Minerva Pediatr."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10545-015-9866-0","article-title":"Concomitant immune-related events in Wilson disease: Implications for monitoring chelator therapy","volume":"39","author":"Seessle","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_171","first-page":"269","article-title":"Lupus \u00e9ryth\u00e9mateux induit par la p\u00e9nicillamine au cours d\u2019une maladie de Wilson [Lupus erythematosus due to penicillamine associated with Wilson\u2019s disease]","volume":"122","author":"Boudin","year":"1971","journal-title":"Ann. Med. Interne"},{"key":"ref_172","first-page":"336","article-title":"Syndr\u00f3m podobn\u00fd syst\u00e9mov\u00e9mu lupus erythematosus vyvolan\u00fd penicilam\u00ednom u pacienta s Wilsonovou chorobou [A syndrome similar to systemic lupus erythematosus caused by penicillamine in patients with Wilson\u2019s disease]","volume":"84","author":"Kalina","year":"1985","journal-title":"Bratisl. Lek. Listy"},{"key":"ref_173","first-page":"552","article-title":"Lupus eritematoso sist\u00e9mico inducido por d-penicilamina en enfermedad de Wilson: A prop\u00f3sito de un caso [Systemic lupus erythematosus induced by d-penicillamine in Wilson\u2019s disease: Apropos of a case]","volume":"88","year":"1987","journal-title":"Med. Clin."},{"key":"ref_174","first-page":"153","article-title":"Pemphigus, polymyosite et myasth\u00e9nie induits par la D-p\u00e9nicillamine [D-penicillamine-induced pemphigus, polymyositis and myasthenia]","volume":"126","author":"Jan","year":"1999","journal-title":"Ann. Dermatol. Venereol."},{"key":"ref_175","unstructured":"Electronic Medicines Compendium (2024, July 03). D-penicillamine Summary of Product Characteristic. Available online: https:\/\/www.medicines.org.uk\/emc."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"595","DOI":"10.5603\/PJNNS.a2021.0080","article-title":"D-penicillamine-induced lupus erythematosus as an adverse reaction of treatment of Wilson\u2019s Disease","volume":"55","author":"Antos","year":"2021","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Antos, A., Cz\u0142onkowska, A., Bembenek, J., Kurkowska-Jastrz\u0119bska, I., and Litwin, T. (2023). D-Penicillamine-Induced Myasthenia Gravis-A Probable Complication of Wilson\u2019s Disease Treatment-A Case Report and Systematic Review of the Literature. Life, 13.","DOI":"10.3390\/life13081715"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"644","DOI":"10.31729\/jnma.7607","article-title":"D-penicillamine induced myasthenia gravis in Wilson\u2019s disease: A case report","volume":"60","author":"Thapa","year":"2022","journal-title":"JNMA J. Nepal Med. Assoc."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.21037\/atm.2019.04.31","article-title":"The interesting case-orphan diseases-double trouble","volume":"7","author":"Reuner","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"ref_180","first-page":"323","article-title":"Concurrent massive breast enlargement, myasthenia gravis and dermopathy as manifestations of penicillamine toxicity in a Wilson\u2019s disease patient","volume":"67","author":"Tan","year":"2012","journal-title":"Med. J. Malaysia"},{"key":"ref_181","first-page":"293","article-title":"D-Penicillamine induced myasthenia gravis","volume":"7","author":"Varghese","year":"2002","journal-title":"Neurosciences"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0002-9343(77)90153-X","article-title":"Penicillamine-associated myasthenia gravis, antiacetylcholine receptor and antistriational antibodies","volume":"63","author":"Masters","year":"1977","journal-title":"Am. J. Med."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/bmj.2.5973.726-a","article-title":"Myasthenia syndrome during penicillamine treatment","volume":"28","author":"Czlonkowska","year":"1975","journal-title":"Br. Med. J."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ejcts\/ezu309","article-title":"Prognostic factors of remission in myasthenia gravis after thymectomy","volume":"48","author":"Mao","year":"2015","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0165-5728(99)00038-7","article-title":"T cell responses to D-penicillamine in drug-induced myasthenia gravis: Recognition of modified DR1:peptide complexes","volume":"97","author":"Hill","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/ard.41.6.617","article-title":"Multiple side effects of penicillamine therapy in one patient with rheumatoid arthritis","volume":"41","author":"Essigman","year":"1982","journal-title":"Ann. Rheum. Dis."},{"key":"ref_187","first-page":"1171","article-title":"D-penicillamine and the ocular myasthenic syndrome","volume":"13","author":"Kimbrough","year":"1981","journal-title":"Ann. Ophthalmol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3389\/fneur.2020.00660","article-title":"Mu-SK-associated myasthenia gravis: Clinical features and management","volume":"11","author":"Rodolico","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1590\/S0004-282X1984000400010","article-title":"Myasthenia gravis induced by D-penicillamine in a patient with progressive systemic sclerosis","volume":"42","author":"Marchiori","year":"1984","journal-title":"Arq. Neuropsiquiatr."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF00607425","article-title":"The influence of prolonged treatment with D-penicillamine on the immune response in Wilson\u2019s disease","volume":"12","year":"1977","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1212\/01.WNL.0000137021.90567.37","article-title":"Effect of D-penicillamine on neuromuscular junction in patients with Wilson disease","volume":"63","author":"Patil","year":"2004","journal-title":"Neurology"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/jmd2.12317","article-title":"Autoantibodies in Wilson disease: Impact on clinical course","volume":"63","author":"Eyileten","year":"2022","journal-title":"JIMD Rep."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbi.2021.05.017","article-title":"Antibodies to neuronal surface antigens in patients with a clinical diagnosis of neurodegenerative disorder","volume":"96","author":"Giannoccaro","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Giannoccaro, M.P., Verde, F., Morelli, L., Rizzo, G., Ricciardiello, F., and Liguori, R. (2023). Neural Surface Antibodies and Neurodegeneration: Clinical Commonalities and Pathophysiological Relationships. Biomedicines, 11.","DOI":"10.3390\/biomedicines11030666"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2013.04.007","article-title":"Positivity of serum \u201cclassical\u201d onconeural antibodies in a series of 2063 consecutive patients with suspicion of paraneoplastic neurological syndrome","volume":"259","author":"Gromadzka","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Ja\u0144czyk, W., Bier\u0142a, J.B., Trojanowska, I., Wierzbicka-Ruci\u0144ska, A., Cukrowska, B., and Socha, P. (2023). Prevalence and Significance of Autoantibody Seropositivity in Children with Wilson\u2019s Disease. Diagnostics, 13.","DOI":"10.3390\/diagnostics13040768"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"e29043","DOI":"10.5812\/hepatmon.29043","article-title":"Simultaneous Presentation of Wilson\u2019s Disease and Autoimmune Hepatitis; A Case Report and Review of Literature","volume":"15","author":"Dara","year":"2015","journal-title":"Hepat. Mon."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/cmi.2016.3","article-title":"Liver immunology and its role in inflammation and homeostasis","volume":"13","author":"Robinson","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the liver\u2014From homeostasis to disease","volume":"13","author":"Heymann","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_200","first-page":"2485","article-title":"Co-occurring Wilson\u2019s disease and non-penicillamine-induced systematic lupus erythematosus: A case report and literature review","volume":"6","author":"Shi","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"ref_201","first-page":"100","article-title":"A case of fulminant hepatic failure in Wilson\u2019s disease combined with systemic lupus erythematosus","volume":"8","author":"Kim","year":"2002","journal-title":"Taehan Kan Hakhoe Chi= Korean J. Hepatol."},{"key":"ref_202","first-page":"81","article-title":"Wilson\u2019s Disease with Systemic Lupus Erythematosus","volume":"64","author":"Santhakumar","year":"2016","journal-title":"J. Assoc. Physicians India"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/20469047.2018.1443411","article-title":"Wilson disease and lupus nephritis: Is it coincidence or a true association?","volume":"39","author":"Pradhan","year":"2018","journal-title":"Paediatr. Int. Child Health"},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Wang, D., Wei, W., and Zeng, X. (2018). Wilson\u2019s disease combined with systemic lupus erythematosus: A case report and literature review. BMC Neurol., 18.","DOI":"10.1186\/s12883-018-1085-5"},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Xu, L., Liu, B., Liu, Z., Tang, N., She, C., Wang, J., Zang, B., and Yang, Y. (2021). Co-occurrence of Wilson\u2019s disease and systemic lupus erythematosus: A case report and literature review. BMC Gastroenterol., 2.","DOI":"10.1186\/s12876-021-01814-5"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1296426","DOI":"10.3389\/fped.2023.1296426","article-title":"A rare concomitance of Wilson\u2019s disease and systemic lupus erythematosus in a teenage girl: A case report and literature review","volume":"11","author":"Yang","year":"2024","journal-title":"Front. Pediatr."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"keac496-079","DOI":"10.1093\/rheumatology\/keac496.079","article-title":"Concomitance of primary systemic lupus erythematosus and Wilson\u2019s disease in a male child: A case report","volume":"61","author":"Hadef","year":"2022","journal-title":"Rheumatology"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5114\/reum.2019.87622","article-title":"Systemic lupus erythematosus, hypoparathyroidism, and hemolytic anemia in a patient with Wilson\u2019s disease","volume":"57","author":"Mageed","year":"2019","journal-title":"Reumatologia"},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Yang, Z., Li, Q., Liu, S., Zong, Z., Yu, L., and Sun, S. (2024). Systemic lupus erythematosus combined with Wilson\u2019s disease: A case report and literature review. BMC Pediatr., 24.","DOI":"10.1186\/s12887-024-04713-2"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1177\/0961203320923398","article-title":"Hepatic manifestations in systemic lupus erythematosus","volume":"29","year":"2020","journal-title":"Lupus"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3760\/cma.j.issn.0366-6999.20121153","article-title":"Clinical and immunopathological features of patients with lupus hepatitis","volume":"126","author":"Zheng","year":"2013","journal-title":"Chin. Med. J."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1034\/j.1600-0676.2000.020005366.x","article-title":"The liver in collagen diseases: Pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver","volume":"20","author":"Matsumoto","year":"2000","journal-title":"Liver"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0046-8177(92)90033-Y","article-title":"The liver in systemic lupus erythematosus: Pathologic analysis of 52 cases and review of Japanese Autopsy Registry Data","volume":"23","author":"Matsumoto","year":"1992","journal-title":"Hum. Pathol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"e230721","DOI":"10.1136\/bcr-2019-230721","article-title":"Wilson\u2019s disease presentation resembling autoimmune hepatitis","volume":"12","author":"Santos","year":"2019","journal-title":"BMJ Case Rep."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1046\/j.1440-1746.2000.02158.x","article-title":"Wilson\u2019s disease with superimposed autoimmune features: Report of two cases and review","volume":"15","author":"Milkiewicz","year":"2000","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group report: Review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J. Hepatol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2015). EASL clinical practice guidelines: Autoimmune hepatitis. J. Hepatol., 63, 971\u20131004.","DOI":"10.1016\/j.jhep.2015.06.030"},{"key":"ref_219","unstructured":"Scheinberg, I.H., and Sternlieb, I. (1984). Wilson\u2019s Disease, Saunders."},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"European Association for Study of Liver (2012). EASL Clinical Practice Guidelines: Wilson\u2019s disease. J. Hepatol., 56, 671\u2013685.","DOI":"10.1016\/j.jhep.2011.11.007"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"720","DOI":"10.7326\/0003-4819-115-9-720","article-title":"Wilson disease: Clinical presentation, treatment, and survival","volume":"115","author":"Stremmel","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1440-1746.2004.03254.x","article-title":"Wilson\u2019s disease with coexisting autoimmune hepatitis","volume":"19","author":"Yener","year":"2004","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1399-3046.2005.00254.x","article-title":"Fulminant hepatic failure: Wilson\u2019s disease or autoimmune hepatitis? Implications for transplantation","volume":"9","author":"Santos","year":"2005","journal-title":"Pediatr. Transplant."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"277","DOI":"10.32598\/jpr.9.4.988.1","article-title":"Simultaneous Presentation of Autoimmune Hepatitis and Wilson\u2019s Disease: A Systematic Review Study","volume":"9","author":"Nasri","year":"2021","journal-title":"J. Pediatr. Rev."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.msard.2013.09.002","article-title":"Multiple sclerosis in two patients with coexisting Wilson\u2019s disease","volume":"3","author":"Dziezyc","year":"2014","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Despotov, K., Klivenyi, P., Nagy, I., Palvolgyi, A., Vecsei, L., and Rajda, V. (2022). Rare co-occurrence of multiple sclerosis and Wilson\u2019s disease -case report. BMC Neurol., 22.","DOI":"10.1186\/s12883-022-02691-5"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"105507","DOI":"10.1016\/j.clineuro.2019.105507","article-title":"Multiple sclerosis and Wilson disease; a rare coincidence","volume":"186","author":"Yetkin","year":"2019","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_228","first-page":"161","article-title":"High copper and low zinc serum levels in Iranian patients with multiple sclerosis","volume":"58","author":"Ghazavi","year":"2012","journal-title":"Clin. Lab."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ana.21141","article-title":"Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann. Neurol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5114\/polp.2020.94913","article-title":"Autoimmune hepatitis, Wilson\u2019s disease, or both? An analysis of challenging cases","volume":"95","author":"Naorniakowska","year":"2020","journal-title":"Pediatr. Pol. J. Paediatr."},{"key":"ref_231","first-page":"10114","article-title":"Unusual case of Wilson\u2019s disease and coexisting autoimmune hepatitis","volume":"13","author":"Gromny","year":"2019","journal-title":"Biomed. J. Sci. Tech. Res."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1097\/MPG.0000000000000557","article-title":"Acute liver failure because of Wilson disease with overlapping autoimmune hepatitis features: The coexistence of two diseases?","volume":"63","author":"Loudianos","year":"2016","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"109541","DOI":"10.1016\/j.envres.2020.109541","article-title":"Metals, autoimmunity, and neuroendocrinology: Is there a connection?","volume":"187","author":"Dadar","year":"2020","journal-title":"Environ. Res."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1172\/JCI78088","article-title":"Mechanisms of human autoimmunity","volume":"125","author":"Rosenblum","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"7403796","DOI":"10.1155\/2019\/7403796","article-title":"Regulation of Inflammation in Autoimmune Disease","volume":"2019","author":"Duan","year":"2019","journal-title":"J. Immunol. Res."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41584-018-0109-2","article-title":"Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis","volume":"15","author":"Chen","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2174\/187152808785748155","article-title":"Therapeutic benefits of regulating inflammation in autoimmunity","volume":"7","author":"Nikoopour","year":"2008","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.autrev.2018.01.020","article-title":"NLRP3: A promising therapeutic target for autoimmune diseases","volume":"17","author":"Shen","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/35100573","article-title":"From T to B and back again: Positive feedback in systemic autoimmune disease","volume":"1","author":"Shlomchik","year":"2001","journal-title":"Nat. Rev. Immunol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev-immunol-020711-074934","article-title":"Immune regulatory function of B cells","volume":"30","author":"Mauri","year":"2012","journal-title":"Ann. Rev Immunol."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jbspin.2012.04.010","article-title":"Regulatory B cells play a key role in immune system balance","volume":"80","author":"Berthelot","year":"2013","journal-title":"Jt. Bone Spine"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0005-2760(92)90015-N","article-title":"Role of lipoprotein-copper complex in copper catalyzed- peroxidation of low-density lipoprotein","volume":"1123","author":"Kuzuya","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1039\/C0MT00044B","article-title":"A comparison of methionine, histidine and cysteine in copper(I)-binding peptides reveals differences relevant to copper uptake by organisms in diverse environments","volume":"3","author":"Rubino","year":"2011","journal-title":"Metallomics"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1021\/acs.analchem.7b03144","article-title":"Effect of antigen retrieval methods on nonspecific binding of antibody\u2013metal nanoparticle conjugates on formalin-fixed paraffin-embedded tissue","volume":"90","author":"Zhang","year":"2017","journal-title":"Anal. Chem."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/0748233717733852","article-title":"Neural autoantibodies in patients with neurological symptoms and histories of chemical\/mold exposures","volume":"34","author":"Lieberman","year":"2018","journal-title":"Toxicol. Ind. Health."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nchembio773","article-title":"Noble metals strip peptides from class II MHC proteins","volume":"2","author":"Painter","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"ref_247","doi-asserted-by":"crossref","unstructured":"Vohr, H.W. (2016). Trace metals and the immune system. Encyclopedia of Immunotoxicology, Springer.","DOI":"10.1007\/978-3-642-54596-2"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1590\/1806-9282.63.12.1090","article-title":"The role of regulatory T cells, interleukin-10 and in vivo scintigraphy in autoimmune and idiopathic diseases-therapeutic perspectives and prognosis","volume":"63","author":"Campos","year":"2017","journal-title":"Rev. Assoc. Med. Bras."},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"Vohr, H.W. (2016). Metals and autoimmune disease. Encyclopedia of Immunotoxicology, Springer.","DOI":"10.1007\/978-3-642-54596-2"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2500\/aap.2016.37.3928","article-title":"Th1\/Th2\/Th17 cells imbalance in patients with asthma with and without psychological symptoms","volume":"37","author":"Zhu","year":"2016","journal-title":"Allergy Asthma Proc."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2119\/molmed.2013.00164","article-title":"The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases","volume":"20","author":"Magna","year":"2014","journal-title":"Mol. Med."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1084\/jem.20120189","article-title":"Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release","volume":"209","author":"Venereau","year":"2012","journal-title":"J. Exp. Med."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s10020-020-0144-8","article-title":"Expression of Concern to: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)","volume":"26","author":"Yang","year":"2020","journal-title":"Mol. Med."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1074\/jbc.M306793200","article-title":"Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein","volume":"279","author":"Park","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"C917","DOI":"10.1152\/ajpcell.00401.2005","article-title":"High mobility group box 1 protein interacts with multiple toll-like receptors","volume":"290","author":"Park","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1189\/jlb.1008585","article-title":"HMGB1 loves company","volume":"86","author":"Bianchi","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"e0458","DOI":"10.1097\/HC9.0000000000000458","article-title":"Autoimmune hepatitis: Current and future therapies","volume":"8","author":"Reau","year":"2024","journal-title":"Hepatol. Commun."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1586\/egh.12.40","article-title":"Drug choices in autoimmune hepatitis: Part A\u2014Steroids","volume":"6","author":"Czaja","year":"2012","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/ccr3.2125","article-title":"A case report and focused literature review of d-penicillamine and severe neutropenia; a serious toxicity from seldom-used drug","volume":"7","author":"Pitman","year":"2019","journal-title":"Clin. Case Rep."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.12998\/wjcc.v9.i6.1386","article-title":"Wilson disease\u2014The impact of hyperimmunity on disease activity: A case report","volume":"9","author":"Stremmel","year":"2021","journal-title":"World J. Clin. Cases"},{"key":"ref_261","first-page":"448","article-title":"Steroids used to desensitize penicillamine allergy in Wilson disease","volume":"40","author":"Hsu","year":"1999","journal-title":"Acta Paediatr. Taiwan."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.iliver.2022.09.002","article-title":"Latest innovations in the treatment of Wilson\u2019s disease","volume":"1","author":"Zheng","year":"2022","journal-title":"iLiver"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1034\/j.1600-0676.2003.00824.x","article-title":"Diagnosis and phenotypic classification of Wilson disease","volume":"23","author":"Ferenci","year":"2003","journal-title":"Liver Int."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jceh.2018.08.009","article-title":"Wilson\u2019s disease: Clinical Practice Guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of India","volume":"9","author":"Nagral","year":"2019","journal-title":"J. Clin. Exp. Hepatol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/16\/9034\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:39:45Z","timestamp":1760110785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/16\/9034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":264,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["ijms25169034"],"URL":"https:\/\/doi.org\/10.3390\/ijms25169034","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,20]]}}}